Global Rho(D) Immune Globulin Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rho(D) Immune Globulin Market Insights, Forecast to 2034
Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
Global Rho(D) Immune Globulin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rho(D) Immune Globulin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Rho(D) Immune Globulin, also known as anti-Rh factor immunoglobulin, is a biological product used to prevent Rh hemolytic disease of the newborn in cases where an Rh-negative mother is carrying an Rh-positive fetus. In the market, driven by advancements in medical technology and awareness, there is a steady growth in demand for Rho(D) immune globulin. Currently, the product finds extensive application in the fields of prenatal care and obstetrics, particularly in high-risk pregnancies to prevent Rh hemolytic disease. With ongoing advancements in biologic manufacturing techniques, the future development of Rho(D) immune globulin might focus on refinement to enhance efficacy and reduce side effects, catering to the continually expanding market needs.
Report Covers
This report presents an overview of global Rho(D) Immune Globulin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rho(D) Immune Globulin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
5 ml
10 ml
Government Institution
Private Sector
Others
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rho(D) Immune Globulin plant distribution, commercial date of Rho(D) Immune Globulin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rho(D) Immune Globulin introduction, etc. Rho(D) Immune Globulin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rho(D) Immune Globulin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Rho(D) Immune Globulin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Rho(D) Immune Globulin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Rho(D) Immune Globulin, also known as anti-Rh factor immunoglobulin, is a biological product used to prevent Rh hemolytic disease of the newborn in cases where an Rh-negative mother is carrying an Rh-positive fetus. In the market, driven by advancements in medical technology and awareness, there is a steady growth in demand for Rho(D) immune globulin. Currently, the product finds extensive application in the fields of prenatal care and obstetrics, particularly in high-risk pregnancies to prevent Rh hemolytic disease. With ongoing advancements in biologic manufacturing techniques, the future development of Rho(D) immune globulin might focus on refinement to enhance efficacy and reduce side effects, catering to the continually expanding market needs.
Report Covers
This report presents an overview of global Rho(D) Immune Globulin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Rho(D) Immune Globulin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics
Segment by Type
5 ml
10 ml
Segment by Application
Government Institution
Private Sector
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Rho(D) Immune Globulin plant distribution, commercial date of Rho(D) Immune Globulin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Rho(D) Immune Globulin introduction, etc. Rho(D) Immune Globulin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Rho(D) Immune Globulin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices